Subject "7.30.30.04 Action to combat drugs and drug-trafficking"
subscribeDossiers (78)
Evaluation of the EU Drugs Strategy 2013-2020 and the EU Action Plan on Drugs 2017-2020. Executive summary
Evaluation of the EU Drugs Strategy 2013-2020 and the EU Action Plan on Drugs 2017-2020
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): 2018 evaluation. Accompanying document
Single Convention on Narcotic Drugs (1961), as amended by the 1972 Protocol, and the Convention on Psychotropic Substances (1971): scheduling of substances. EU position
EU roadmap to fight drug trafficking and organised crime
Decisions of the Commission on Narcotic Drugs. EU position
Decisions of the Commission on Narcotic Drugs. EU position
Decisions of the Commission on Narcotic Drugs. EU position
EU Agenda and Action Plan on Drugs 2021-2025
United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances: addition to the list of substances. EU position
Single Convention on Narcotic Drugs (1961), as amended by the 1972 Protocol, and the Convention on Psychotropic Substances (1971): scheduling of substances. EU position
Single Convention on Narcotic Drugs (1961), as amended by the 1972 Protocol, and the Convention on Psychotropic Substances (1971): scheduling of substances. EU position
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): 2018 evaluation
Inclusion of the drug precursor Isopropylidene (2-(3,4-methylenedioxyphenyl)acetyl)malonate (IMDPAM) and other substances in the list of scheduled substances
Inclusion of certain drug precursors in the list of scheduled substances
Inclusion of certain drug precursors in the list of scheduled substances
Inclusion of new psychoactive substances in the definition of 'drug'
European Union Drugs Agency
Inclusion of the new psychoactive substances methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (MDMB-4en-PINACA) and methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA) in the definition of ‘drug’
Inclusion of the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene) in the definition of 'drug' (amend. the Annex to Council Framework Decision 2004/757/JHA)
Inclusion of certain drug precursors in the list of scheduled substances
Inclusion of new psychoactive substances in the definition of 'drug'
Inclusion of certain drug precursors in the list of scheduled substances
Subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures
Subjecting the new psychoactive substance methyl 2-{[1-(5-fluoropentyl)-1Hindazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA) to control measures
Subjecting the new psychoactive substance methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil) to control measures
Subjecting the new psychoactive substance 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) to control measures
Subjecting the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide (tetrahydrofuranylfentanyl; THF-F) to control measures
Subjecting the new psychoactive substance N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) to control measures
Subjecting the new psychoactive substance N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) to control measures
Subjecting the new psychoactive substance N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl)propanamide (4-fluoroisobutyrylfentanyl) to control measures
Subjecting the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl) to control measures
Subjecting N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl) to control measures
Inclusion of certain drug precursors in the list of scheduled substances
Preparation for the UN General Assembly special session on drugs
Subjecting the new psychoactive substance methyl 2-[[1-(cyclohexylmethyl)-1Hindole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) to control measures
New psychoactive substances: information exchange, early warning system and risk assessment procedure
Subjecting the new psychoactive substance 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures
Subjecting 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-DMAR) and 1 cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45) to control measures
Subjecting 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) to control measures
New psychoactive substances
Minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking: definition of 'drug'
Subjecting 5-(2-aminopropyl)indole to control measures
Subjecting 4-methylamphetamine to control measures
EU/Russia agreement: drug precursors
Monitoring intra-EU trade in drug precursors
Monitoring EU/third country trade in drug precursors
Justice Programme 2014-2020
EU/Croatia agreement: participation of Croatia in the work of the European Monitoring Centre for Drugs and Drug Addiction
Green Paper on the role of civil society in drugs policy in the EU
Production of opium for medical purposes in Afghanistan
Narcotic and psychotropic substances: defining 1-benzylpiperazine BZP as a new synthetic drug which is to be made subject to control measures and criminal provisions
Area of freedom, security and justice: strategy for the external dimension, action plan implementing the Hague Programme
Agreement EC/Bulgaria: participation in the work of the European Monitoring Centre for Drugs and Drug Addiction
Agreement EC/Turkey: participation in the work of the European Monitoring Centre for Drugs and Drug Addiction EMCDDA
EC/Romania agreement: participation in the work of the European Monitoring Centre for Drugs and Drug Addiction
EC/Norway agreement: European Monitoring Centre for Drugs and Drug Addiction EMCDDA, revision of the amount of the financial contribution
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Recast
General programme "Fundamental Rights and Justice": specific programme "Drugs prevention and information", 2007-2013
Draft European Union drugs strategy for 2005 to 2012
Fight against drugs : suppression by customs administrations of illicit trafficking on the high seas. Initiative Spain
Combatting drugs: information exchange, risk-assessment and control of new psychoactive substances
Narcotic drugs and psychotropic substances: trade in drug precursors, monitoring and surveillance
Combating illicit drug trafficking: criminal acts and penalties, minimum provisions. Framework Decision
Fight against drugs: transmission of samples of illegal narcotic substances. Initiative Sweden
Police cooperation: European system of laboratories for analyses of synthetic drugs. Initiative Sweden
Action to combat drugs: action plan 2000-2004
EC/Norway agreement: participation in the work of the European Monitoring Centre for Drugs and Drug Addiction EMCDDA
European monitoring centre for drugs and addiction EMCDDA: assistance to applicant countries (amend. Regulation (EEC) No 302/93)
Fight against drugs: Post-1999 Union's strategy. Report, European Council of Cardiff 1998
Fight against drugs, international cooperation: Union's platform for the UN special session June 1998, UNGASS
Narcotics and psychotropic drugs: substances used in the illicit manufacture of drugs
Europol Drugs Unit: annual report 1996
European Monitoring Centre for Drugs and Drug Addiction EMCDDA: drugs in the Union. Annual report 1997
Control of new synthetic drugs, designer drugs
Fight against drugs in developing countries: North-South cooperation in the fight of drugs and drug dependence
Fight against drugs: European action plan 1995-1999
Decentralized Community agencies: establishment of the European Monitoring Centre for Drugs and Drug Addiction EMCDDA (amend. Regul. 302/93/EEC)
Subscribe